TARS - Tarsus reports positive Phase 2 results for Lyme disease product
2024-02-22 11:50:42 ET
More on Tarsus Pharmaceuticals
- Tarsus Pharmaceuticals: 3 Clinical Catalysts In The Next 4 Months, Xdemvy Launch Underway
- Seeking Alpha’s Quant Rating on Tarsus Pharmaceuticals
- Historical earnings data for Tarsus Pharmaceuticals
- Financial information for Tarsus Pharmaceuticals